Home

imati prst u pita Nebo Gurnuti gilead medicine Posrnuti slavina Rasplod

Gilead says generic Truvada will be available in 2020
Gilead says generic Truvada will be available in 2020

Gilead Assistance Programs For HIV, Hep B Drugs Will Dial Back  Reimbursement To 340B Providers :: Pink Sheet
Gilead Assistance Programs For HIV, Hep B Drugs Will Dial Back Reimbursement To 340B Providers :: Pink Sheet

Gilead Revenue Soars on Hepatitis C Drug - The New York Times
Gilead Revenue Soars on Hepatitis C Drug - The New York Times

AHF • AHF Calls on Gilead to Set Up $10 Billion Fund for Victims Harmed by  its TDF-based Drugs
AHF • AHF Calls on Gilead to Set Up $10 Billion Fund for Victims Harmed by its TDF-based Drugs

U.K. marketing police slam Gilead for claiming Biktarvy tolerability beats  GSK rival | Fierce Pharma
U.K. marketing police slam Gilead for claiming Biktarvy tolerability beats GSK rival | Fierce Pharma

Gilead reaches multiyear agreement with White House to donate PrEP
Gilead reaches multiyear agreement with White House to donate PrEP

Gilead's (GILD) Sunlenca Wins FDA Approval for HIV Resistant to Other Drugs  - Bloomberg
Gilead's (GILD) Sunlenca Wins FDA Approval for HIV Resistant to Other Drugs - Bloomberg

Gilead prices remdesivir at $2,340 per patient for developed countries
Gilead prices remdesivir at $2,340 per patient for developed countries

Gilead Sciences, Inc.
Gilead Sciences, Inc.

Gilead reports 3% revenue growth in Q1 2022
Gilead reports 3% revenue growth in Q1 2022

Gilead says counterfeiters sold $250M worth of fake HIV drugs, sues  distributors | Fierce Pharma
Gilead says counterfeiters sold $250M worth of fake HIV drugs, sues distributors | Fierce Pharma

Single patient study adds to debate over Gilead's remdesivir for COVID-19 |  Reuters
Single patient study adds to debate over Gilead's remdesivir for COVID-19 | Reuters

Top Research Reports for JPMorgan, Gilead Sciences & CSX
Top Research Reports for JPMorgan, Gilead Sciences & CSX

United States v. Gilead: The Fight for PrEP | Bill of Health
United States v. Gilead: The Fight for PrEP | Bill of Health

Gilead to donate HIV prevention drug Truvada to 200K uninsured patients
Gilead to donate HIV prevention drug Truvada to 200K uninsured patients

Gilead to Slice List Prices of Liver Drugs - WSJ
Gilead to Slice List Prices of Liver Drugs - WSJ

Change to Gilead assistance program threatens PrEP access, HIV advocates  say | PBS NewsHour
Change to Gilead assistance program threatens PrEP access, HIV advocates say | PBS NewsHour

Gilead Grants $24M to Improve Access, Care for HIV Communities
Gilead Grants $24M to Improve Access, Care for HIV Communities

NYC DOHMH Advisory about Tampered and/or Counterfeit Versions of Biktarvy  and Descovy - GMHC
NYC DOHMH Advisory about Tampered and/or Counterfeit Versions of Biktarvy and Descovy - GMHC

Gilead to launch generic versions of hepatitis C drugs | Modern Healthcare
Gilead to launch generic versions of hepatitis C drugs | Modern Healthcare

Patients sue Gilead, saying drug company intentionally delayed safer HIV  medicine - Los Angeles Times
Patients sue Gilead, saying drug company intentionally delayed safer HIV medicine - Los Angeles Times

Xaiver University of Louisiana's College of Pharmacy is collaborating with  Gilead Sciences and Morehouse School of Medicine to address health  inequities - Xavier University of Louisiana
Xaiver University of Louisiana's College of Pharmacy is collaborating with Gilead Sciences and Morehouse School of Medicine to address health inequities - Xavier University of Louisiana

Gilead Advancing Access®: What to Know | Prism Health North Texas
Gilead Advancing Access®: What to Know | Prism Health North Texas

Pharma giant Gilead sued for 'withholding' safer HIV drug | PinkNews
Pharma giant Gilead sued for 'withholding' safer HIV drug | PinkNews

Gilead's Veklury expands FDA nod to patients outside the hospital as oral  version heads to trial | Fierce Pharma
Gilead's Veklury expands FDA nod to patients outside the hospital as oral version heads to trial | Fierce Pharma

PrEP's Still Too Costly For Many People At Risk For HIV : Shots - Health  News : NPR
PrEP's Still Too Costly For Many People At Risk For HIV : Shots - Health News : NPR

Global shortage of key Covid drug leads to NHS rationing | Coronavirus |  The Guardian
Global shortage of key Covid drug leads to NHS rationing | Coronavirus | The Guardian